Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Revenue (2016 - 2025)

Historic Revenue for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Select Medical Holdings' Revenue rose 722.43% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year increase of 542.16%. This contributed to the annual value of $5.2 billion for FY2024, which is 748.3% up from last year.
  • Per Select Medical Holdings' latest filing, its Revenue stood at $1.4 billion for Q3 2025, which was up 722.43% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Revenue registered a high of $1.6 billion during Q1 2022, and its lowest value of -$142.9 million during Q4 2022.
  • Over the past 5 years, Select Medical Holdings' median Revenue value was $1.3 billion (recorded in 2025), while the average stood at $1.3 billion.
  • Its Revenue has fluctuated over the past 5 years, first crashed by 10916.16% in 2022, then soared by 95240.76% in 2023.
  • Quarter analysis of 5 years shows Select Medical Holdings' Revenue stood at $1.6 billion in 2021, then crashed by 109.16% to -$142.9 million in 2022, then skyrocketed by 952.41% to $1.2 billion in 2023, then rose by 7.75% to $1.3 billion in 2024, then increased by 3.88% to $1.4 billion in 2025.
  • Its Revenue stands at $1.4 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.4 billion for Q1 2025.